The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | Haqq Christopher | See Remarks | Grant(A) | 25K | — | $0 |
| Feb 2, 2026 | Haqq Christopher | See Remarks | Grant(A) | 51K | — | $0 |
| Feb 2, 2026 | DeMuth Peter | Chief Scientific Officer | Grant(A) | 21K | — | $0 |
| Feb 2, 2026 | DeMuth Peter | Chief Scientific Officer | Grant(A) | 42K | — | $0 |
| Feb 2, 2026 | Shah Preetam | See Remarks | Grant(A) | 24K | — | $0 |
| Feb 2, 2026 | Shah Preetam | See Remarks | Grant(A) | 48K | — | $0 |
| Feb 2, 2026 | Connelly Robert | CEO, President and Director, Director | Grant(A) | 74K | — | $0 |
| Feb 2, 2026 | Connelly Robert | CEO, President and Director, Director | Grant(A) | 147K | — | $0 |
| Dec 9, 2025 | DeMuth Peter | Chief Scientific Officer | Option exercise(M) | 362 | $4.41 | $2K |
| Dec 9, 2025 | DeMuth Peter | Chief Scientific Officer | Option exercise(M) | 362 | — | $0 |
| Jun 3, 2025 | Chudnovsky Yekaterina | Director, 10% Owner | Grant(A) | 103K | — | $0 |
| May 19, 2025 | Chudnovsky Yekaterina | Director, 10% Owner | Grant(A) | 8K | — | $0 |
| May 19, 2025 | Ruffolo Robert R | Director | Grant(A) | 8K | — | $0 |
| May 19, 2025 | Wilson Karen J | Director | Grant(A) | 8K | — | $0 |
| May 19, 2025 | Adams Julian | Director | Grant(A) | 8K | — | $0 |
| May 19, 2025 | Venkatesan Jay | Director | Grant(A) | 8K | — | $0 |
| May 19, 2025 | Nissenson Allen | Director | Grant(A) | 8K | — | $0 |
| May 19, 2025 | Ashe Carol Gail | Director | Grant(A) | 8K | — | $0 |
| Apr 15, 2025 | Shah Preetam | See Remarks | Grant(A) | 192K | — | $0 |
| Mar 5, 2025 | Chudnovsky Yekaterina | Director, 10% Owner | Conversion(C) | 3.5M | $5.81 | $20.3M |
| Mar 5, 2025 | Chudnovsky Yekaterina | Director, 10% Owner | Conversion(C) | 3.4M | $5.81 | $20.0M |
| Feb 3, 2025 | Connelly Robert | CEO, President and Director, Director | Grant(A) | 122K | — | $0 |
| Feb 3, 2025 | Haqq Christopher | See Remarks | Grant(A) | 44K | — | $0 |
| Feb 3, 2025 | DeMuth Peter | Chief Scientific Officer | Grant(A) | 44K | — | $0 |
| Dec 16, 2024 | DeMuth Peter | Chief Scientific Officer | Option exercise(M) | 381 | $4.41 | $2K |
| Dec 16, 2024 | DeMuth Peter | Chief Scientific Officer | Option exercise(M) | 381 | — | $0 |
| Nov 26, 2024 | Venkatesan Jay | Director | Option exercise(X) | 50K | $0.01 | $500 |
| Nov 26, 2024 | Venkatesan Jay | Director | Option exercise(X) | 50K | — | $0 |
| Nov 21, 2024 | Nissenson Allen | Director | Grant(A) | 4K | — | $0 |
| Nov 21, 2024 | Chudnovsky Yekaterina | Director, 10% Owner | Grant(A) | 4K | — | $0 |
| Nov 21, 2024 | Ruffolo Robert R | Director | Grant(A) | 4K | — | $0 |
| Nov 21, 2024 | Venkatesan Jay | Director | Grant(A) | 4K | — | $0 |
| Nov 21, 2024 | Ashe Carol Gail | Director | Grant(A) | 4K | — | $0 |
| Nov 21, 2024 | Adams Julian | Director | Grant(A) | 4K | — | $0 |
| Nov 21, 2024 | Wilson Karen J | Director | Grant(A) | 4K | — | $0 |
| Sep 30, 2024 | Haqq Christopher | See Remarks | Grant(A) | 28K | — | $0 |
| Sep 30, 2024 | DeMuth Peter | Chief Scientific Officer | Grant(A) | 30K | — | $0 |
| Sep 30, 2024 | Connelly Robert | CEO, President and Director, Director | Grant(A) | 92K | — | $0 |
| Aug 12, 2024 | Chudnovsky Yekaterina | Director, 10% Owner | Buy(P) | 3.4M | $5.81 | $20.0M |
| Jun 28, 2024 | Venkatesan Jay | Director | Buy(P) | 50K | $4.99 | $250K |
| Jun 28, 2024 | Venkatesan Jay | Director | Buy(P) | 50K | — | $0 |
| Jun 28, 2024 | Chudnovsky Yekaterina | Director, 10% Owner | Buy(P) | 1.6M | — | $0 |
| Jun 28, 2024 | Chudnovsky Yekaterina | Director, 10% Owner | Buy(P) | 1.6M | $4.99 | $8.0M |
| Mar 19, 2024 | GKCC, LLC | 10% Owner | Buy(P) | 1.0M | $5.81 | $6.0M |
| Feb 1, 2024 | Piekos Brian | Chief Financial Officer | Grant(A) | 43K | — | $0 |
| Feb 1, 2024 | Connelly Robert | CEO, President and Director, Director | Grant(A) | 225K | — | $0 |
| Feb 1, 2024 | Haqq Christopher | See Remarks | Grant(A) | 28K | — | $0 |
| Feb 1, 2024 | DeMuth Peter | Chief Scientific Officer | Grant(A) | 342 | — | $0 |
| Feb 1, 2024 | DeMuth Peter | Chief Scientific Officer | Grant(A) | 30K | — | $0 |
| Dec 28, 2023 | Nissenson Allen | Director | Grant(A) | 4K | — | $0 |
| Dec 28, 2023 | Chudnovsky Yekaterina | Director, 10% Owner | Grant(A) | 4K | — | $0 |
| Dec 28, 2023 | Wilson Karen J | Director | Grant(A) | 4K | — | $0 |
| Dec 28, 2023 | Ashe Carol Gail | Director | Grant(A) | 4K | — | $0 |
| Dec 28, 2023 | Venkatesan Jay | Director | Grant(A) | 4K | — | $0 |
| Dec 28, 2023 | Adams Julian | Director | Grant(A) | 4K | — | $0 |
| Dec 28, 2023 | Ruffolo Robert R | Director | Grant(A) | 4K | — | $0 |
| Dec 22, 2023 | GKCC, LLC | 10% Owner | Buy(P) | 1.2M | $5.81 | $7.0M |
| Jun 1, 2023 | Piekos Brian | Chief Financial Officer | Grant(A) | 75K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).